BioCryst's total assets for Q2 2025 were $457.19M, a decrease of -4.76% from the previous quarter. BCRX total liabilities were $878.78M for the fiscal quarter, a -5.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.